Randomized, phase III, double-blind, vehicle-controlled clinical trial to evaluate the safety and efficacy of 12 weeks of twice-daily azelaic acid foam, 15% in papulopustular rosacea

被引:0
作者
Draelos, Zoe D. [1 ]
Elewski, Boni E. [2 ]
Harper, Julie C. [3 ]
Sand, Meike [4 ]
Staedtler, Gerald [4 ]
Nkulikiyinka, Richard [4 ]
Shakery, Kaweh [4 ]
机构
[1] Dermatol Consulting Serv, High Point, NC USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
[3] Dermatol & Skin Care Ctr Birmingham PC, Birmingham, AL USA
[4] Bayer Healthcare, Global Dev, Berlin, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
850
引用
收藏
页码:AB59 / AB59
页数:1
相关论文
共 50 条
[31]   Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology [J].
Szeimies, RM ;
Gerritsen, MJR ;
Gupta, G ;
Ortonne, JP ;
Serresi, S ;
Bichel, J ;
Lee, JH ;
Fox, TL ;
Alomar, A .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 51 (04) :547-555
[32]   Safety and tolerability of twice-daily balsalazide tablets: Results of a phase 3, randomized, double-blind, placebo-controlled, multicenter study [J].
Pruitt, Ronald E. ;
Rosen, Alan A. ;
Wruble, Lawrence ;
Sedghi, Shahriar ;
Shepard, Roland D. ;
Mareya, Shadreck M. ;
Huang, Shirley ;
Shaw, Audrey L. ;
Forbes, William F. .
GASTROENTEROLOGY, 2008, 134 (04) :A494-A494
[33]   Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial [J].
Eggert Stockfleth ;
Ralph von Kiedrowski ;
Rolf Dominicus ;
John Ryan ;
Adam Ellery ;
Meritxell Falqués ;
Nathalie Ivanoff ;
Rosario Rodriguez Azeredo .
Dermatology and Therapy, 2017, 7 :263-263
[34]   A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia [J].
Hiroyoshi Ohta ;
Hiroshi Oka ;
Chie Usui ;
Masayuki Ohkura ;
Makoto Suzuki ;
Kusuki Nishioka .
Arthritis Research & Therapy, 14
[35]   A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia [J].
Ohta, Hiroyoshi ;
Oka, Hiroshi ;
Usui, Chie ;
Ohkura, Masayuki ;
Suzuki, Makoto ;
Nishioka, Kusuki .
ARTHRITIS RESEARCH & THERAPY, 2012, 14 (05)
[36]   Two weeks of twice-daily prism adaptation treatment does not improve posture or gait in Parkinson’s disease: a double-blind randomized controlled trial [J].
Janet H. Bultitude ;
Dawna M. Pidgeon ;
Pauline R. LeBlanc ;
Charlotte A. Jeffreys ;
Faith P. Alexandre ;
Stephen L. Lee .
Trials, 22
[37]   Two weeks of twice-daily prism adaptation treatment does not improve posture or gait in Parkinson's disease: a double-blind randomized controlled trial [J].
Bultitude, Janet H. ;
Pidgeon, Dawna M. ;
LeBlanc, Pauline R. ;
Jeffreys, Charlotte A. ;
Alexandre, Faith P. ;
Lee, Stephen L. .
TRIALS, 2021, 22 (01)
[38]   A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (ATOPICLAIR™) in the management of atopic dermatitis in paediatric patients [J].
Patrizi, Annalisa ;
Capitanio, Bruno ;
Neri, Iria ;
Giacomini, Federica ;
Sinagra, Jo L. ;
Raone, Beatrice ;
Berardesca, Enzo .
PEDIATRIC ALLERGY AND IMMUNOLOGY, 2008, 19 (07) :619-625
[39]   Efficacy and Safety of Once-Daily Luliconazole 1% Cream in Patients ≥12 Years of Age With Interdigital Tinea Pedis: A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Study [J].
Jarratt, Michael ;
Jones, Terry ;
Adelglass, Jeffrey ;
Bucko, Alicia ;
Pollak, Richard ;
Roman-Miranda, Amaury ;
Olin, Jason T. ;
Swinyer, Leonard .
JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (07) :838-846
[40]   Efficacy and safety of permethrin 5% topical gel vs. placebo for rosacea: a double-blind randomized controlled clinical trial [J].
Raoufinejad, K. ;
Mansouri, P. ;
Rajabi, M. ;
Naraghi, Z. ;
Jebraeili, R. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (12) :2105-2117